Levalbuterol
Levalbuterol is a short-acting selective beta-2 adrenergic agonist used to relieve bronchospasm and prevent or treat reversible airway obstruction in conditions such as asthma and certain cases of chronic obstructive pulmonary disease (COPD). It works by stimulating beta-2 receptors in bronchial smooth muscle, causing airway relaxation and improving airflow. It is commonly available as a metered-dose inhaler and nebuliser solution for inhalation, with dosing based on the patient’s age, condition, and response to treatment. Common side effects include tremors, nervousness, headache, palpitations, and increased heart rate. Important precautions include monitoring for paradoxical bronchospasm, cardiovascular effects, and reduced potassium levels, particularly in patients with heart disease or those using other sympathomimetic medicines. Levalbuterol should be used according to medical advice, and increasing reliance on rescue medication may indicate worsening asthma requiring clinical reassessment.
Levalbuterol was historically used as a respiratory medicine for the symptomatic management of certain respiratory conditions. Its former uses included:
is okay
The import of medicines into India is regulated by the Central Drugs Standard Control Organisation (CDSCO) under the Drugs and Cosmetics Act, 1940, and the Drugs and Cosmetics Rules, 1945. The regulatory requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished formulation, or an unapproved medicine intended for an individual patient's treatment.
Primeera Healthcare Private Limited can provide import coordination and pharmaceutical documentation assistance for Levalbuterol, subject to confirmation of its current regulatory status and eligibility for import into India.
The export of Levalbuterol from India is subject to applicable requirements under the Drugs and Cosmetics Act, 1940, the Drugs and Cosmetics Rules, 1945, and relevant export, customs, and destination-country regulations. Documentation requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished pharmaceutical formulation, or a medicine intended for a specific market. Export eligibility and destination-country requirements must be verified before shipment.
Primeera Healthcare Private Limited can provide pharmaceutical export documentation assistance, regulatory coordination, and shipping support for Levalbuterol, subject to confirmation of its export eligibility under applicable Indian regulations and the import requirements of the destination country.
If you have any questions or need any help, contact our Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
All Trademarks and Brands that appear on the website belong to their respective owners. Primeera Healthcare does not lay any claim on them; we only provide information.
